Latest AI and machine learning research in dementia for healthcare professionals.
BACKGROUND: Beta amyloid in the brain, which was originally confirmed by post-mortem examinations, can now be confirmed in living patients using amyloid positron emission tomography (PET) tracers, and the accuracy of diagnosis can be improved by beta amyloid plaque confirmation in patients. Amyloid deposition in the brain is often associated with the expression of dementia. Hence, it is important ...
BACKGROUND: Alzheimer's disease has become one of the most common neurodegenerative diseases worldwide, which seriously affects the health of the elderly. Early detection and intervention are the most effective prevention methods currently. Compared with traditional detection methods such as traditional scale tests, electroencephalograms, and magnetic resonance imaging, speech analysis is more con...
BACKGROUND: Social robots have demonstrated promising outcomes in terms of increasing the social health and well-being of people with dementia and mil...
BACKGROUND AND OBJECTIVE: Mild cognitive impairment (MCI) is a transitional state between normal aging and Alzheimer's disease (AD), and accurately pr...
Dementia affects the patient's memory and leads to language impairment. Research has demonstrated that speech and language deterioration is often a cl...
Deep neural networks are increasingly used for neurological disease classification by MRI, but the networks' decisions are not easily interpretable by...
PURPOSE: We present a systematic literature review of dialogue agents for Artificial Intelligence (AI) and agent-based conversational systems dealing ...
Exploring individual brain atrophy patterns is of great value in precision medicine for Alzheimer's disease (AD) and mild cognitive impairment (MCI). ...
Deep neural networks have been successfully applied to generate predictive patterns from medical and diagnostic data. This paper presents an approach ...
Selection of differentially expressed genes (DEGs) is a vital process to discover the causes of diseases. It has been shown that modelling of genomics...
The study aims to implement a convolutional neural network framework that uses the 18F-FDG PET modality of brain imaging to detect multiple stages of ...
An objective biomarker to predict the outcome of isolated rapid eye movement sleep behavior disorder (iRBD) is crucial for the management. This study ...
Alzheimer's disease is a neurodegenerative condition that gradually impairs cognitive abilities. Recently, various neuroimaging modalities and machine...
OBJECTIVES: Pet robots are technology-based substitutes for live animals that have demonstrated psychosocial benefits for people living with dementia ...
Alzheimer's disease (AD), a neurodegenerative disorder characterized by progressive cognitive decline, is generally prevalent in elderly people with s...
The limited accessibility of medical specialists for Alzheimer's disease (AD) can make obtaining an accurate diagnosis in a timely manner challenging ...
With modern population growth and an increase in the average lifespan, more patients are becoming afflicted with neurodegenerative diseases such as de...
Alzheimer's disease (AD) is currently diagnosed using a mixture of psychological tests and clinical observations. However, these diagnoses are not per...
Early diagnosis of Alzheimer's disease plays a pivotal role in patient care and clinical trials. In this study, we have developed a new approach based...
BACKGROUND: Dementia develops as cognitive abilities deteriorate, and early detection is critical for effective preventive interventions. However, mai...